Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04800965 · ClinicalTrials.gov registry record · NA
Text-based Interventions to Promote COVID-19 Vaccinations
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 200,000
- Enrollment target
NCT04800965 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 200,000 participants.
The verdict
NCT04800965, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 200,000 participants
- Enrollment target
Study Summary
This study investigates whether and which type of text-based interventions affect the take-up of the COVID-19 vaccine.
Interventions
- BEHAVIORAL Patient MyChart Scheduling Link
- BEHAVIORAL Patient Educational Video
- BEHAVIORAL Enhanced Follow through Message
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200,000 participants |
| Start Date | 2021-01-31 |
| Est. Completion | 2022-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04800965
The ClinicalTrials.gov registry entry for NCT04800965 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Patient MyChart Scheduling Link is the first listed.
NCT04800965 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04800965 about?
NCT04800965 is a clinical study titled "Text-based Interventions to Promote COVID-19 Vaccinations". This study investigates whether and which type of text-based interventions affect the take-up of the COVID-19 vaccine.
What is the current status of trial NCT04800965?
This trial is currently completed. It is a NA study. The enrollment target is 200,000 participants. The study started on 2021-01-31. Estimated completion is 2022-01-01.
What interventions are being tested in trial NCT04800965?
The interventions under investigation include: Patient MyChart Scheduling Link (BEHAVIORAL), Patient Educational Video (BEHAVIORAL), Enhanced Follow through Message (BEHAVIORAL).
Who is sponsoring clinical trial NCT04800965?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.